Drugs / Biologic Lung Volume Reduction
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00630227 | Feb 2008 → Dec 2009 | pulmonary emphysema | Aeris Therapeutics | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Biologic Lung Volume Reduction | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00630227 ↗ |
| Known as | BLVR | “Aeris Therapeutics has developed the Biologic Lung Volume Reduction (BLVR) System which is intended to achieve lung volume reduction without surgery and its attendant risks.” NCT00630227 ↗ |
| Modality | Other / unclassified | “The treatment delivers a precisely proportioned proprietary mixture of drugs and biologics which, when combined at the treatment site, form a biodegradable hydrogel.” NCT00630227 ↗ |
| Route | Other | “Patients are treated using a bronchoscope to direct treatment to the most damaged areas of the lung or in the case of homogeneous disease, areas that are less active as shown...” NCT00630227 ↗ |